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Abstract
Background: Type D (distressed) personality has been associated with adverse cardiac prognosis and poor
emotional well-being in cardiac patients, but it is still unclear what mechanisms link Type D personality with poor
clinical outcomes in cardiac patients. In the present cohort of Icelandic cardiac patients, we examined potential
pathways that may explain this relationship. The objectives were to examine 1) the association between Type D
personality and impaired psychological status, and to explore whether this association is independent of disease
severity; and 2) the association between Type D personality and an unhealthy lifestyle.
Methods: A sample of 268 Icelandic coronary angiography patients (74% males (N = 199); mean age 62.9 years
(SD 10.5), range 28-85 years) completed the Type D Scale (DS14), Hospital Anxiety and Depression Scale (HADS),
and Perceived Stress Scale (PSS) at hospitalization. Health-related behaviors were assessed 4 months following
angiography. Clinical data were collected from medical files.
Results: Type D personality was associated with an increased risk of anxiety (OR 2.97, 95% CI:1.55-5.69), depression
(OR 4.01, 95% CI:1.42-11.29), and stress (OR 5.99, 95% CI:3.08-11.63), independent of demographic variables and
disease severity. Furthermore, fish consumption was lower among Type Ds, as 21% of Type Ds versus 5% of non-
Type Ds consumed fish < 1 a week (p < 0.001). Type D patients were also more likely to smoke at follow-up (22%
versus 10%, p = 0.024) and to use antidepressants (17% versus 9%, p = 0.049) and sleeping pills (49% versus 33%, p
= 0.019) compared to non-Type Ds. Type D personality was not associated with other health-related behaviors,
aside from trends towards less fruit and vegetable consumption, and more weight gain.
Conclusion: Type D personality was associated with psychological distress and an unhealthy lifestyle in Icelandic
cardiac patients. Future studies should further investigate the association between Type D personality and health-
related behaviors.
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Background
Evidence linking psychological factors with adverse
prognosis in patients suffering from cardiovascular dis-
ease (CVD) has accumulated in recent years [1,2]. In
this realm of research, one specific personality construct,
the Type D (distressed) personality, has shown particu-
lar promise as a potential risk factor for poor prognosis
in CVD patients. Type D personality refers to high
scores on two stable personality traits, negative affectiv-
ity (NA) and social inhibition (SI), and portrays indivi-
duals who frequently experience negative emotions
(elevated NA), but tend to inhibit emotional expression
due to fear of rejection (elevated SI) [3]. This combina-
tion of elevated negative affect and high social inhibition
is thought to have a negative impact on clinical out-
comes in cardiac patients, rather than one of the two
personality traits alone [4].
The Type D personality concept was originally devel-
oped to identify cardiac patients at risk of developing
emotional and interpersonal difficulties [3,5], and has as
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such, been strongly associated with psychological
comorbidity in cardiac patients, e.g. post-traumatic
stress disorder [6], anxiety [7-9], depression [9,10], and
vital exhaustion [11]. However, further research revealed
that Type D personality is also associated with increased
morbidity [12], mortality [13-15] and a poor quality of
life [16] across diverse CVD patient groups, where it has
been associated with a 3-fold increased risk of poor
prognosis [17]. Several studies have demonstrated that
the effect of Type D personality on adverse outcomes is
independent of biomedical risk factors, such as hyper-
tension [14,16] and disease severity, comprised by multi-
vessel disease and left ventrical function [14,18].
With a prevalence of 25-38% in cardiac patients
[14,19-21], Type D personality can potentially influence
the prognosis and well-being of a substantial number of
cardiac patients.
It is still unclear what mechanisms link Type D per-
sonality with poor clinical outcomes in CVD patients
[22]. Mediating mechanisms may include both physiolo-
gical and behavioral factors [13,23,24]. Recent findings
have suggested that negative health-related behavior [22]
and inadequate consultation behavior [25] may play a
role in the behavioral factor vicinity. Individuals experi-
encing psychological distress may for instance be more
prone to use maladaptive coping styles, such as
increased smoking and poor diet [26], which again can
negatively impact the disease process. Further investiga-
tions on how Type D personality influences the health
of cardiac patients are needed, especially since such ana-
lysis would provide clues for possible targets for inter-
vention in these patients [13,14]. In addition, there is
also a need for more cross-cultural investigations on
Type D personality and its influence, since previous
investigations have primarily focused on samples of Bel-
gian and Dutch origin [27].
The aim for the present study was twofold: (1) to
investigate the relationship of Type D personality with
anxiety, depression and stress in Icelandic cardiac
patients, and to explore whether this association is inde-
pendent of indicators of disease severity; and (2) to
investigate the relationship of Type D personality with
certain health-related behaviors in these patients.
Methods
Participants
The original participant sample consisted of 315 patients
who underwent a coronary angiography at Landspitali-
University hospital from January to May 2008. These
patients were a part of a larger study, the “Risk factors,
prognosis and success of medical procedures in patients
undergoing coronary angiography at Landspitali-Univer-
sity Hospital”, and were included in the current study
because they answered additional questionnaires
measuring anxiety, depression and stress at baseline.
Participants were first approached when hospitalized to
the coronary care unit or upon arrival to the emergency
ward. Follow-up assessments were administered with a
phone call to participants in July 2008, approximately
four months after discharge (M = 106 days, (SD 27.2
days)). A total of 268 patients (85%) completed the fol-
low-up, and were included in the final study sample. Of
the excluded 47 patients (15%), six patients (2%) were
deceased, one patient lived abroad and was therefore
not included in follow-up, three individuals (1%) refused
to participate in the follow-up and the remaining 37
(11%) could not be reached. The follow-up group did
not differ in age from the patient group not reached at
follow-up (M = 62.8 years, (SD 10.5) versus M = 65.4
years (SD 9.3), t(313) = 1.56, p = 0.12). The study proto-
col was approved by the medical ethics committee of
The National Bioethics Committee in Iceland. The study
was conducted conform to the ethical tenets developed
by the World Medical Association, as espoused in the
Declaration of Helsinki. All patients provided written
informed consent.
Demographics
Information concerning gender and age was gathered
from medical records, while data concerning educational
level (elementary, higher education (secondary or uni-
versity)) and family status (living alone/widowed, mar-
ried/living with partner) were collected by self-report
from participants.
Clinical variables measured at baseline
Information regarding disease classification, traditional
coronary artery disease (CAD) risk factors, and disease
severity were retrieved from patients’ medical records.
Information on disease status was classified as follows:
CAD, myocardial infarction (MI), arrhythmias, heart valve
disease and heart failure. Traditional CAD risk factors
were defined in the following way: smoking (yes, no);
hypertension (no hypertension treatment, current hyper-
tension treatment); on blood-lipid lowering medication
(no, yes); diabetes (no, yes); and overweight (body mass
index, BMI). Disease severity was defined by a) the num-
ber of coronary arteries affected by CAD (0 or 1 artery
versus ≥ 2 arteries), and b) cardiac history (previous percu-
taneous coronary intervention (PCI), previous MI, and/or
a previous coronary artery bypass surgery (CABG)).
Measures
All participants were administered the Icelandic versions
of the Type D scale (DS14) [19], the Hospital Anxiety
and Depression Scale (HADS) [28], and the Perceived
Stress Scale (PSS) [29] at baseline, when hospitalized for
a coronary angiography.
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The DS14 comprises two seven-item subscales (NA
and SI) in order to measure the tendency to experience
negative emotions (NA, “I am often irritated”) and the
tendency to inhibit self-expression in social interactions
(SI, “I am a closed kind of person”), the two compo-
nents of Type D personality. The report answer format
is on a Likert scale ranging from 0 (false) to 4 (true).
Total scores on both subscales range from 0 to 28. Par-
ticipants were defined as having Type D personality if
they scored ≥ 10 on both subscales [19]. A recent study
using item-response theory has shown the cut of ≥ 10
to be the best to distinguish between Type D and non-
Type D individuals [30]. Results from factor analyses on
the scale have indicated a clear two factor structure,
representing negative affectivity and social inhibition
[19,31,32]. The Icelandic version of the DS14 has good
internal consistency (Cronbach’s a = 0.87-0.88 for NA;
Chronbach’s a = 0.84-0.85 for SI) and psychometric
evaluations have supported the construct validity of the
scale [33].
The HADS measures symptoms of anxiety and
depression and was specifically developed and tested in
physically ill people [28]. This questionnaire contains
seven items for each mood status. Participants answer
on a four-point scale (0-3) how well each statement
refers to them, and total scores for each domain range
from 0 to 21. The Icelandic version of the HADS identi-
fies symptoms of depression and anxiety sufficiently well
[34], and reliability estimates across various studies
range from 0.78-0.86 for anxiety and 0.65-0.85 for
depression [35]. Continuous scores on the HADS were
used for the main analysis and dichotomous scores were
used for a logistic regression. Depression and anxiety
scores on HADS were categorized in a similar way as
recommended by the authors, with the exception that
borderline symptoms and full symptoms were pooled
into one category, such that scores ≥ 8 indicated pre-
sence of symptoms of anxiety and depression.
The PSS is a 14-item questionnaire which measures
perceived stress [29], more specifically, the degree to
which situations in one’s life are appraised as stressful.
Items include questions such as “In the last month, how
often have you felt nervous and stressed” and “In the
last month, how often have you felt that you were
unable to control the important things in your life?”
Responses are measured on a five-point Likert scale ran-
ging from 0 (never) to 4 (very often), and the total score
ranges from 0 to 56. The PSS has good psychometric
properties [29,36]. The Icelandic version of the PSS has
comparable psychometric properties to the original ver-
sion (Davíðsdóttir S, Bachman T, [Association of stress
and gender with health and health-habits], Bachelor’s
thesis, University of Iceland, 1991), with reliability coef-
ficients of a = 0.89 in a healthy sample and a = 0.90 in
a patient sample (Svansdóttir E, [Translation and psy-
chometric evaluation of the DS-14 scale among univer-
sity students and heart patients], cand. psych thesis,
University of Iceland, 2006). In the current study, con-
tinuous scores were used for the main analysis. To indi-
cate heightened symptoms of perceived stress, we used a
cut-off score at the 75th percentile.
Health-related behaviors measured at four-month follow-
up
Assessment of health-related behaviors was conducted
four-months after discharge, by a phone call by a
researcher to participants, where standard questions
regarding exercise, diet, smoking and psychopharmaco-
logical medication use were administered. Specific ques-
tions included: a) whether patients engaged in sufficient
exercise per week (> 20 min 3× a week); b) whether
patients had gained weight after discharge (yes, no); c)
rehabilitation attendance after discharge (yes, no); d)
whether they had breakfast every morning (yes, no); e)
daily consumption of fruits and vegetables (not daily,
daily); f) frequency of fish consumption (< once per
week, weekly); g) smoking (yes, no); and h) regular use
of sleeping pills, antidepressants, and/or anxiety-redu-
cing medication.
Statistical analyses
Prior to analysis, missing values on the DS14, HADS
and PSS were replaced if the number of missing items
per participant did not exceed three on the DS14 and
HADS subscales, or four for the total PSS scale. Missing
items were replaced with each participant’s average
score on the subscale the missing items belonged to.
For each scale, replaced missing items were ≤ 1% of the
total number of items. Four patients (1.5%) did not
complete the HADS scale adequately and were excluded
from all analysis that included HADS scores. Sixteen
patients (6%) had ≥ four items missing on the PSS scale,
and were excluded from analysis involving PSS scores.
Differences in demographics, clinical variables and
health-related behavior between Type D and non-Type
D individuals were explored with chi-square calculations
for nominal variables and independent t-tests for contin-
uous variables. Independent t-tests were administered to
examine basic differences in anxiety, depression and
stress scores between Type D and non-Type D patients.
The association of Type D personality with anxiety,
depression and perceived stress was assessed with multi-
ple linear regressions. Each separate model was imple-
mented with a hierarchical entry, where Type D
personality was inserted at the first step, while age, gen-
der, disease severity, cardiac history, education and
family status were added in the second step as covari-
ates. Two outliers were identified in the anxiety and
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depression models and excluded from further analysis in
those models. Underlying assumptions were inspected
for each regression model and indicated no problems.
The effect size for differences in anxiety, depression,
and perceived stress scores by Type D personality were
estimated using Cohen’s d calculations. Linear regres-
sion analysis was used to test the unique and shared
predictive power of both Type D components for anxi-
ety, depression and stress, where continuous NA and SI
scale scores (0-28) were included as predictors instead
of Type D personality. Each linear regression model was
run twice, first with NA inserted at the first step and SI
at the second step, and then with SI inserted at the first
step and NA at the second step, in order to assess the
unique explained variance of NA and SI. Furthermore, a
logistic regression, which incorporated the same covari-
ates as the linear regression, was conducted to assess
the odds ratio associated with Type D patients for mani-
festation of increased symptoms of anxiety, depression,
and stress. For this analysis, all predictors were inserted
into the model simultaneously using the enter method.
Finally, a re-analysis was conducted for all significant
associations where the Type D/non-Type D categoriza-
tion (≥ 10 on NA and SI) was substituted with continu-
ous NA and SI scale scores [37]. Inter-quartile ranges
were used to rescale NA and SI scores and the NA by
SI interaction term, so that a one unit difference repre-
sented a clinically relevant metric. Within these NA
inter-quartile distribution, 70% (N = 49) of Type Ds fell
within the 4th quartile, and 30% (N = 21) within the
3rd quartile. For SI 49% (N = 34) of Type Ds fell within
the 4th quartile and 51% (N = 36) within the 3rd quar-
tile. In the inter-quartile NA by SI scores, 89% (N = 62)
of Type Ds were within the 4th quartile and 11% (N =
8) within the 3rd quartile. Linear regression models for
anxiety, depression, and stress were re-executed, with
NA, SI and the NA by SI interaction term entered at
the first step and covariates at the second. For health-
related risk markers, binary logistic regression analyses
(stepwise procedure) were used with NA, SI and the NA
by SI interaction term as predictors.
All analyses were two-tailed and alpha < 0.05 was used
to indicate statistical significance. The SPSS 17 statistical
software for windows was used for the analysis (Statisti-
cal Package for Social Sciences, Chicago, IL, USA).
Results
Demographical and clinical variables
Mean age in the sample was 62.9 years (SD 10.5) and
males were more prevalent (74%, N = 199) than females.
A total of 26% of patients were defined as having Type
D personality, which is in line with previous research
[3,19-21]. Baseline characteristics of Type D and non-
Type D individuals are presented in Table 1. Type D
patients were on average younger than non-Type D
patients, but no differences emerged in gender distribu-
tion, family status or educational level between groups.
Likewise, prevalence of traditional CAD risk factors was
similar across groups, except that Type D patients were
less likely to be on hypertension treatment compared to
their non-Type D counterparts. No difference was found
in disease severity, as measured by the number of ves-
sels affected by CAD, nor previous cardiac history (for-
mer PCI, MI and/or CABG) between Type D and non-
Type D participants.
The association of Type D personality with anxiety,
depression and stress
Type D patients had significantly higher anxiety, depres-
sion and perceived stress scores compared to their non-
Type D counterparts (M = 9.7 (SD 2.6) versus M = 7.7
(SD 2.2), t(262) = 5.92, p < 0.001 for anxiety; M = 6.0
(SD 2.3) versus M = 4.7 (SD 1.4), t(86.2) = 5.54, p <
0.001 for depression; M = 21.8 (SD 6.4) versus M = 15.9
(SD 5.7), t(250) = 7.02, p < 0.001 for perceived stress;
see Figure 1). Further analysis with multiple linear
regressions showed that the association between Type D
personality and higher scores on anxiety, depression and
perceived stress was independent of age, gender, family
status, education, disease severity and cardiac history. In
all cases, Type D personality had a strong association at
the first step, (explaining 13%, 11% and 16% of variance
in anxiety, depression and stress scores, respectively),
and the association remained when covariates were
inserted into the model at the second step. The inclu-
sion of covariates contributed to a 6% increase in
explained variance of anxiety scores, but did not signifi-
cantly improve model fit for depression or perceived
stress (see Table 2). The effect sizes associated with
Type D personality were high (Cohen’s d = 0.78, 0.74,
and 0.93 for anxiety, depression, and perceived stress
respectively).
Analysis of the unique and shared predictive power of
both Type D subcomponents revealed that the associa-
tion between Type D and anxiety was primarily driven
by NA (31% of the variance), while the total variance
explained by both factors was 34%. SI did not signifi-
cantly contribute to this model of anxiety; the shared
variance of both factors was 2.5%. Conversely, both NA
and SI contributed to the association with depression
and perceived stress, with 9% shared variance for both
measures. The unique effect of NA was larger in both
cases, with NA and SI explaining 9% and 4% of depres-
sion scores and 17% and 1% in perceived stress scores,
respectively.
Multivariate logistic regression analyses replicated
these findings, indicating that Type D patients had
about three to four times greater odds of experiencing
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some symptoms of anxiety (OR 2.97, 95% CI:1.55-5.69, p
< 0.001) and depression (OR 4.01, 95% CI:1.42-11.29, p
= 0.009), and nearly six times greater odds of heightened
perceived stress (OR 5.99, 95% CI:3.08-11.63, p < 0.001)
compared to non-Type D patients, independent of
covariates.
Health-related behavior
A comparison of health-related behavior four-months
after discharge between groups indicated that diet,
medication use and smoking may differ between Type D
and non-Type D patients (Table 3). First of all, fish con-
sumption was considerably less frequent among Type D
patients. A total of 21% of Type D’s consumed fish less
than once a week compared to only 5% of non-Type D’s
(c 2(1, N = 268) = 16.40; p < 0.001). A trend towards less
consumption of fruits and vegetables in Type D patients
was found as well, but 81% of non-Type Ds versus 70%
of Type Ds consumed fruits and vegetables on a daily
bases (c2(1, N = 267) = 3.44, p = 0.064). However, no
Figure 1 Differences in average anxiety, depression and stress scores by Type D personality (with 95% confidence intervals).
Table 1 Differences in demographical and clinical variables between Type D and non-Type D patients*
Total (N = 268) non-Type D (N = 198) Type D (N = 70) p-value
Demographics
Age Mean (SD) 62.9 (10.5) 63.6 (10.6) 60.7 (10.1) 0.045
Male 74% (199) 73% (146) 27% (53) 0.75
Female 26% (69) 75% (52) 25% (17)
Widowed/Living alone 22% (59) 21% (42) 24% (17) 0.59
Elementary education (N = 267) 39% (105) 38% (75) 43% (30) 0.48
Disease
Coronary artery disease 69% (186) 69% (136) 71% (50)
Myocardial infarction 11% (30) 12% (24) 9% (6)
Arrhythmia 4% (10) 3% (5) 7% (5)
Heart valve disease 4% (12) 5% (10) 3% (2)
Heart failure 2% (4) 2% (3) 1% (1)
Unspecified chest pain/other 10% (26) 10% (20) 9% (6)
CAD risk factors and disease severity**
Hypertension treatment 60% (157) 65% (126) 45% (31) 0.004
High blood-lipids treatment 65% (170) 67% (129) 60% (41) 0.36
Diabetes 11% (29) 11% (22) 10% (7) 0.80
Current smoking (baseline) 22% (59) 19% (38) 30% (21) 0.067
BMI Mean (SD) 28.9 (5.0) 28.9 (4.9) 28.7 (5.1) 0.70
≥ 2 Vessel disease 39% (105) 39% (78) 39% (27) 0.90
Previous PCI, MI or CABG 30% (80) 33% (64) 23% (16) 0.13
* Data are presented as percentages (N) unless otherwise specified
** Due to missing values N varies between 262 and 268 patients
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differences were found regarding whether patients had
breakfast every day. Likewise, no difference was found
in exercise between groups. A trend towards Type D
patients being more likely to have gained weight after
the angiography compared to non-Type D patients was
found although not significant (c2(1, N = 268) = 3.37; p =
0.066). A separate analysis was conducted post hoc in
overweight patients (BMI ≥ 25) to explore this matter
further, and revealed that 18% of overweight Type D
patients reported having gained weight after the angio-
graphy compared to 8% of non-Type D patients (c2(1, N
= 221) = 4.47; p = 0.035).
At follow-up, the prevalence of smoking was 17% in
Type D patients versus 8% in non-Type D patients (c2(1,
N = 266) = 5.09; p = 0.024). A similar trend for smoking
was noted at baseline, although not statistically signifi-
cant. Finally, more patients with Type D personality
reported use of antidepressants (17% versus 9%; c2(1, N =
263) = 3.86; p = 0.049) and sleeping pills (49% versus
33%; c2(1, N = 261) = 5.46; p = 0.019), compared to their
non-Type D counterparts. However, no difference was
found in reported anxiety medication use between
groups.
Secondary analysis of significant results using re-scaled
Type D scale scores
NA was a significant predictor for anxiety (b = 0.65, p <
0.001), depression (b = 0.30, p = 0.006), and stress (b =
0.36, p = 0.001), and SI was a significant predictor for
depression (b = 0.25, p = 0.009). After adjustment for
Table 2 Multiple linear regression of anxiety, depression and perceived stress scores by Type D personality and
covariates
Anxiety (N = 256) Depression (N = 256) Perceived stress (N = 244)
B b R2 B B R2 B b R2
Step 1 0.13 0.11 0.16
Type D personality 1.88 .36** 1.23 .33** 5.76 .41**
Step 2 ΔR2 = 0.06, p = 0.010 ΔR2 = 0.04, p = 0.074 ΔR2 = 0.03, p = 0.22
Type D personality 1.74 .33** 1.19 .32** 5.54 .39**
Age -0.05 -.21** 0.01 .04 -0.09 -.15*
Gender (female) 0.80 .15* -0.63 -.17* 0.51 .04
Family status (married) 0.29 .05 -0.39 -.10 -0.33 -.02
Higher education -0.18 -.04 -.45 -.13* -1.24 -.10
≥ 2 Vessel disease -0.02 -.00 -0.28 -.08 0.27 .02
Previous cardiac history -0.06 -.01 -0.10 -.03 0.83 .06
*p ≤ 0.05; **p ≤ 0.001
Table 3 Prevalence of certain health-related behavior practices across groups at follow-up*
N Total non-Type D Type D p-value
Exercise
Minimal exercise (< 20 min 3× a week) 268 11% (29) 11% (21) 11% (8) 0.85
Have attended rehabilitation 263 30% (78) 28% (55) 33% (23) 0.43
Weight
Gained weight after the angiography 268 11% (30) 9% (18) 17% (12) 0.066
Gained weight (obese patients, BMI ≥ 25) 221 10% (23) 8% (13) 18% (10) 0.035
Diet
Have breakfast every day 267 90% (240) 91% (179) 87% (61) 0.38
Consume fruits and vegetables every day 267 78% (208) 81% (159) 70% (49) 0.064
Consume fish seldom (≤ 1 a week) 268 9% (25) 5% (10) 21% (15) 0.001
Smoking
Smoking prevalence at follow-up 266 10% (27) 8% (15) 17% (12) 0.024
Psychopharmacological medication use
Use sleeping pills regularly 261 37% (96) 33% (63) 49% (33) 0.019
Use antidepressants regularly 263 11% (29) 9% (17) 17% (12) 0.049
Use anxiety-reducing medication regularly 263 12% (32) 11% (22) 15% (10) 0.49
*Data are presented as percentages (N) unless otherwise specified
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these NA and SI main effects, the interaction term of
NA by SI was not significant in these analyses of anxi-
ety, depression and stress. In binary logistic regression
models of health-related behaviors, the NA by SI inter-
action term was associated with higher odds of smoking
at follow-up (OR 1.50, 95% CI: 1.01-2.21, p = 0.04) and
less fish consumption (OR 0.48, 95% CI: 0.31-0.74, p =
0.001), and NA with more use of antidepressant medica-
tions (OR 1.89, 95% CI: 1.29-2.77, p = 0.001). No asso-
ciation was found between NA, SI, or NA by SI with
weight gain (in patients with BMI ≥ 25) or use of sleep
medication.
Discussion
This study investigated the association between Type D
personality and psychological distress in Icelandic car-
diac patients, explored whether the association was con-
founded by indicators of disease severity, and examined
the relationship between Type D personality and certain
health-related behaviors. As expected, patients with
Type D personality had a worse psychological status
compared to their non-Type D counterparts, which was
independent of the patient’s demographic status and
markers of disease severity. These results are in support
for the notion that Type D personality is associated with
impaired psychological well-being in cardiac patients,
and are congruent with previous findings [8,9], where
Type D has been associated with a three-fold risk of
increased psychological distress [17]. Further analysis
revealed that the association between Type D and poor
psychological status was mainly driven by NA, but that
SI also had a significant unique contribution to depres-
sion and perceived stress. NA and SI shared consider-
able variance in depression/stress scores, indicating the
effect of Type D personality. Other researchers also
found that the interaction of NA and SI predicted
increased stress levels [24].
Regarding health-related behaviors, Type D patients
displayed a lower prevalence of fish consumption and a
trend towards less fruit and vegetable consumption
compared to non-Type Ds, as well as a predisposition to
smoke at follow-up and a higher prevalence of sleep-
and antidepressant medication use. The higher preva-
lence of psychopharmacological medication use has
been noticed previously, where post-MI patients with a
Type D personality were significantly more likely to use
benzodiazepines as compared to non-Type D patients
[38], and provides further support to the current find-
ings that Type D individuals experience more symptoms
of anxiety, depression and stress.
The finding that Type D personality was not asso-
ciated with indicators of disease severity is in line with
previous findings [14,18,39], providing further evidence
that Type D personality is not related to disease severity.
Other studies also found no association between psy-
chological factors and extent of coronary atherosclerosis
[40]. Hence, the adverse effects of Type D personality
on cardiac prognosis may be mediated through other
pathways, such as behavioral and physiological factors
[13,23,24].
Apart from the unexpected link between Type D and
a lower prevalence of hypertension treatment, no asso-
ciation was found with the traditional CAD risk factors.
This fits well with the general consensus that the influ-
ence of Type D on cardiac health is not mediated
through biomedical risk factors [14,16]. The lower
hypertension treatment prevalence could be due to a
poorer self-management in Type D patients, as Type D
has previously been associated with poor medication
adherence [41]. Type D individuals are also less likely to
seek appropriate medical care [42] or to have regular
medical check-ups [22].
Re-analyses of significant associations of Type D per-
sonality with outcome variables, using continuous NA,
SI, and NA by SI scores confirmed the association of
the NA and SI subscales with depression, and the main
effects of NA with anxiety and stress. The NA by SI
interaction term was not significant in these analyses,
probably as the main effects of the Type D subcompo-
nents were already accounted for. Regarding health-
behaviors, the NA by SI interaction term was associated
with more smoking and lower fish consumption and
NA with use of antidepressant medications. These find-
ings suggest that categorical and dimensional definitions
of Type D personality are not necessarily mutually
exclusive, but represent two different ways of capturing
the psychological profiles of individuals [43].
Behavioral processes are believed to constitute one of
the main mediating mechanisms linking personality and
psychological distress with impaired health [44] and
increased CVD risk [23,26], and recent findings suggest
that health-related behavior may explain 40% of the
association between personality traits and mortality [45].
Thus, management of behavioral processes such as
health-related behavior may be crucial to reduce dis-
tress-related CVD risk [23]. The current findings sug-
gested that some important aspects of health-related
behavior may differ between Type D and non-Type D
patients. A distinct difference in fish consumption was
found, and previously, Type D personality has been
associated with less sensible diet in healthy individuals
[22]. Healthy diet choices are considered an important
part of CVD risk reduction [46], where for example
increased consumption of fruits and vegetables [47,48],
fish, and reduced intake of fried foods [46,47] are
recommended. Unhealthy diet has been associated with
an increased risk of acute myocardial infarction world-
wide, and is estimated to account for nearly 30% of the
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population attributable risk [47]. Thus, a predisposition
towards unhealthy diet choices is a plausible mediating
mechanism in the relationship between Type D person-
ality and clinical CVD events, and as such, should be
inspected more thoroughly.
Although no differences in exercise and rehabilitation
were found, a trend towards a higher prevalence of
weight gain was noticed in Type D patients, which was
significant in a post hoc analysis in overweight patients.
Hence, overweight Type D patients may be more prone
to gain weight after a coronary angiography, although
how much weight these participants gained is unknown.
Weight loss is of significant importance in obese indivi-
duals, and cardiac patients in particular, as it can
improve or prevent many of the obesity-related risk fac-
tors for coronary heart diseases [49].
Type D patients were more likely to smoke at follow-
up than non-Type D patients, although this difference
was not significant at baseline. Other studies have also
found an association between Type D personality and
smoking [33,50,51]. Difficulties with maintaining smok-
ing abstinence have been related to neuroticism [52,53]
and psychological distress [52]. Type D individuals may
experience the prospect of smoke-cessation as a more
threatening and stressful event, due to their tendency to
experience things in a more negative way, and might
therefore need more support with altering their smoking
habits. Taken together, Type D individuals may need
more assistance with smoking cessation and other
health-related behaviors, such as changing dietary habits.
Behavioral interventions to reduce psychological distress
might facilitate more successful modifications of
unhealthy lifestyles [54].
Assessment of Type D personality could be useful to
identify patients who have an increased risk of adverse
clinical events [17]. Type D personality has also been
associated with inadequate consultation behavior
[25,55], poor medication adherence [41] and negative ill-
ness perception [56] in cardiac patients. Rozanski [57]
has argued that cardiologists should consider including
a brief screening of psychological factors that might
influence patient behavior and adherence into their
standard care. The DS14 is a short, reliable measure of
Type D that is easy to administer (2-3 minutes) and
score [19], and that could be used by health profes-
sionals to identify Type D patients that may benefit
from more tailored intervention in clinical care.
Little is known about the population attributable risk
Type D poses for CVD incidence in the community, as
the main emphasizes in Type D research has not been
to assert causal connection with CVD incidence, but
rather to examine the association between general dis-
tress and prognosis in cardiovascular populations [17].
As a consequence, most studies on Type D personality
and coronary heart disease have been conducted in car-
diovascular samples. Yet, a number of general popula-
tion studies on Type D personality have exposed Type
D personality as a vulnerability factor for worse self-
reported health status, more somatic health complaints
and disease-promoting mechanism [58] and unhealthier
lifestyle behaviors [22].
Finally, the current findings support the cross-cultural
validity for the association of Type D personality with
psychological distress, and are consistent with recent
finding from Denmark [59], Germany [60] and the Uni-
ted States [61]. Thus, the effect of Type D personality is
not limited to Dutch and Belgian populations [9].
The results of the current study should be interpreted
with some caution due to the following limitations. The
participant sample consisted of a heterogeneous group of
cardiac patients undergoing coronary angiography, and
thus measurements of disease severity employed in this
study may not portray effectively worse disease status for a
small proportion of the sample (for instance in arrhythmia
patients). In addition, the current findings regarding Type
D and psychological status might be susceptible for reverse
causation, due to the cross-sectional origin, but previous
longitudinal reports demonstrating that Type D predicts
onset, prevalence and severity of psychological distress
after adjustments for baseline depression [17] diminish
such a risk. Furthermore, health-related behaviors were
assessed with self-report and not by extensive and psycho-
metrically examined measurement devices. Yet, the cur-
rent sample represented a broad group of cardiac patients
undergoing a coronary angiography in the only hospital in
Iceland that performs angiographies, and thus the sample
portrays effectively the population of cardiac patients of a
whole nation as non-selectively as possible.
Conclusions
In summary, the results of the present study indicate
that Type D personality is associated with more psycho-
logical distress and unhealthy lifestyle behaviors in Ice-
landic cardiac patients, and support the cross-cultural
validity of the Type D personality construct. Further stu-
dies should be implemented to investigate, in more
detail, the association between Type D personality and
health-related behavior, for such investigations could
generate intervention strategies to improve the prognos-
tic outlook for cardiac patients with Type D personality.
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